PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
14762932-9	2004	All the calcium phosphate-coated-ZrO(2) scaffolds showed higher ALP levels compared to pure ZrO(2) scaffold.	zro(2)	33-39	alkaline phosphatase, placental	Homo sapiens	64-67
17376524-1	2007	OBJECTIVES: Due to its high fracture toughness ceria-stabilized ZrO(2)/Al(2)O(3) nanocomposite (Ce-TZP/A) could be superior to Y-TZP in clinical use.	zro(2)	64-70	PHD finger protein 20	Homo sapiens	99-102
15627643-5	2004	Exposure to nanoparticles of ZrO(2) (and to a lesser extent TiO(2)), upregulated expression of viral TLR receptors TLR3 and TLR7.	zro(2)	29-35	toll like receptor 3	Homo sapiens	115-119
15627643-5	2004	Exposure to nanoparticles of ZrO(2) (and to a lesser extent TiO(2)), upregulated expression of viral TLR receptors TLR3 and TLR7.	zro(2)	29-35	toll like receptor 7	Homo sapiens	124-128
21871723-1	2011	This study investigated the effects of in situ ZrO(2) nanoparticle formation on properties of granulated activated carbon (GAC) and their impacts on arsenic and organic co-contaminant removal.	zro(2)	47-53	glutaminase	Homo sapiens	123-126
23218279-3	2013	We describe the positive influences of ZrO(2) surface-modified with pcHAgel (Zr-3) containing two different loads of growth and differentiation factor-5 (GDF-5) to aid new bone formation as compared to the same amount of BMP-2 (Zr-4-7).	zro(2)	39-45	growth differentiation factor 5	Homo sapiens	117-152
23218279-3	2013	We describe the positive influences of ZrO(2) surface-modified with pcHAgel (Zr-3) containing two different loads of growth and differentiation factor-5 (GDF-5) to aid new bone formation as compared to the same amount of BMP-2 (Zr-4-7).	zro(2)	39-45	growth differentiation factor 5	Homo sapiens	154-159
12798071-4	2003	Our results showed that direct exposure to cpTi and ZrO(2) particles compromises cell viability through the induction of apoptosis, eliciting increased levels of the tumor suppressor proteins p53 and p73, in a manner dependent on material composition, particle dosage, and time.	zro(2)	52-58	tumor protein p53	Homo sapiens	192-195
12798071-4	2003	Our results showed that direct exposure to cpTi and ZrO(2) particles compromises cell viability through the induction of apoptosis, eliciting increased levels of the tumor suppressor proteins p53 and p73, in a manner dependent on material composition, particle dosage, and time.	zro(2)	52-58	tumor protein p73	Homo sapiens	200-203
23018082-3	2012	METHODS: To address the hypothesis that using a ZrO(2)/hydroxyapatite (HAp) composite might improve both the mechanical properties and cellular compatibility of the porous material, we fabricated ZrO(2)/HAp composite scaffolds with different ZrO(2)/HAp ratios, and evaluated their characteristics.	zro(2)	48-54	reticulon 3	Homo sapiens	71-74
23018082-3	2012	METHODS: To address the hypothesis that using a ZrO(2)/hydroxyapatite (HAp) composite might improve both the mechanical properties and cellular compatibility of the porous material, we fabricated ZrO(2)/HAp composite scaffolds with different ZrO(2)/HAp ratios, and evaluated their characteristics.	zro(2)	48-54	reticulon 3	Homo sapiens	203-206
23018082-3	2012	METHODS: To address the hypothesis that using a ZrO(2)/hydroxyapatite (HAp) composite might improve both the mechanical properties and cellular compatibility of the porous material, we fabricated ZrO(2)/HAp composite scaffolds with different ZrO(2)/HAp ratios, and evaluated their characteristics.	zro(2)	48-54	reticulon 3	Homo sapiens	203-206
23018082-3	2012	METHODS: To address the hypothesis that using a ZrO(2)/hydroxyapatite (HAp) composite might improve both the mechanical properties and cellular compatibility of the porous material, we fabricated ZrO(2)/HAp composite scaffolds with different ZrO(2)/HAp ratios, and evaluated their characteristics.	zro(2)	196-202	reticulon 3	Homo sapiens	71-74
23018082-3	2012	METHODS: To address the hypothesis that using a ZrO(2)/hydroxyapatite (HAp) composite might improve both the mechanical properties and cellular compatibility of the porous material, we fabricated ZrO(2)/HAp composite scaffolds with different ZrO(2)/HAp ratios, and evaluated their characteristics.	zro(2)	196-202	reticulon 3	Homo sapiens	71-74
23018082-5	2012	RESULTS: The porosity of a ZrO(2)/HAp scaffold can be adjusted from 72% to 91%, and the compressive strength of the scaffold increased from 2.5 to 13.8MPa when the ZrO(2) content increased from 50 to 100wt%.	zro(2)	27-33	reticulon 3	Homo sapiens	34-37
23018082-6	2012	The cell adhesion and proliferation in the ZrO(2)/HAp scaffold was greatly improved when compared to the scaffold made with ZrO(2) alone.	zro(2)	43-49	reticulon 3	Homo sapiens	50-53
23018082-6	2012	The cell adhesion and proliferation in the ZrO(2)/HAp scaffold was greatly improved when compared to the scaffold made with ZrO(2) alone.	zro(2)	124-130	reticulon 3	Homo sapiens	50-53
21889841-1	2011	New nano hybrid material (ZrO(2)/B(2)O(3)) was synthesized and applied as a sorbent for the separation and/or preconcentration of Co(II), Cu(II) and Cd(II) in water and tea leaves prior to their determination by flame atomic absorption spectrometry.	zro(2)	26-32	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	130-136
19135350-1	2009	A zirconia (ZrO(2)) adsorption-based immunoassay by electrochemical quartz crystal microbalance (EQCM) has been initially developed, aiming at the detection of phosphorylated acetylcholinesterase (Phospho-AChE) as a potential biomarker for bio-monitoring exposures to organophosphate (OP) pesticides and chemical warfare agents.	zro(2)	12-18	acetylcholinesterase (Cartwright blood group)	Homo sapiens	175-195
21286943-2	2011	Zirconia (ZrO(2)) was added in microwell for adsorption of acetylcholinesterase (AChE).	zro(2)	10-16	acetylcholinesterase (Cartwright blood group)	Homo sapiens	59-79
21286943-2	2011	Zirconia (ZrO(2)) was added in microwell for adsorption of acetylcholinesterase (AChE).	zro(2)	10-16	acetylcholinesterase (Cartwright blood group)	Homo sapiens	81-85
20416409-1	2010	STATEMENT OF PROBLEM: Ceria-stabilized tetragonal ZrO(2)/Al(2)O(3) nanocomposite (Ce-TZP/A) offers superior properties compared to yttria-stabilized zirconia (Y-TZP).	zro(2)	50-56	PHD finger protein 20	Homo sapiens	85-88
19135350-1	2009	A zirconia (ZrO(2)) adsorption-based immunoassay by electrochemical quartz crystal microbalance (EQCM) has been initially developed, aiming at the detection of phosphorylated acetylcholinesterase (Phospho-AChE) as a potential biomarker for bio-monitoring exposures to organophosphate (OP) pesticides and chemical warfare agents.	zro(2)	12-18	acetylcholinesterase (Cartwright blood group)	Homo sapiens	205-209
19135350-3	2009	The resulting ZrO(2) film was utilized to selectively capture Phospho-AChE from the sample media.	zro(2)	14-20	acetylcholinesterase (Cartwright blood group)	Homo sapiens	70-74
19188096-0	2009	Direct electron transfer and electrocatalysis of myoglobin loaded in layer-by-layer films assembled with nonionic poly(ethylene glycol) and ZrO(2) nanoparticles.	zro(2)	140-146	myoglobin	Homo sapiens	49-58